NVAX Insider Trading Activity and SEC Form 4 Filings
NVAX insider trading summary
No open-market insider purchases or sales of Novavax Inc (NVAX) have been reported on SEC Form 4 in the past 12 months.
Latest NVAX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 31, 2024 | James F Young | Insider | Sell | $43K (5,400 @ $8.00) |
| Dec 24, 2024 | James F Young | Insider | Sell | $39K (4,600 @ $8.48) |
| Dec 13, 2024 | Rachel K. King | Insider | Sell | $37K (4,150 @ $9.02) |
| Jun 21, 2024 | James F Young | Insider | Sell | $106K (7,500 @ $14.09) |
| Jun 18, 2024 | James F Young | Insider | Sell | $16K (1,107 @ $14.28) |
| Jun 18, 2024 | James F Young | Insider | Sell | $87K (6,393 @ $13.62) |
| Jun 17, 2024 | Filip Dubovsky | President, R&D | Sell | $181K (12,500 @ $14.46) |
| Jun 17, 2024 | Filip Dubovsky | President, R&D | Sell | $20K (1,404 @ $14.54) |
| May 14, 2024 | Filip Dubovsky | President, R&D | Sell | $658K (47,312 @ $13.90) |
| Mar 10, 2023 | Gregory M Glenn | President, R&D | Buy | $7K (1,000 @ $6.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.